Clinical Trials List

A state-of-the-art clinical research facility located in Ozark, Missouri..

AbbVie - 3110-305-002:

Pediatric Migraine

Having a migraine is hard. It can be even harder to watch your child experience a painful and debilitating migraine without the ability to help.


We are inviting you to take part in a clinical study for children and adolescents of 6 to 17 years of age who suffer from migraines. All study-related visits, tests, and investigational product will be provided at no cost. In addition, you may receive compensation for your time and travel. No health insurance is required to participate.

You, or your child may qualify for the PERISCOPE Study if you or they:

  • Are between the ages of 6-17 years old

  • Have been experiencing migraines for at least 6 months

  • Experience between 1 and 14 migraine attacks per month

All study-related visits, tests, and investigational product will be provided at no cost to you or your insurance. In addition, compensation for time and travel may be provided. The PERISCOPE Study is evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.

Biohaven/Pfizer 311/312:

A clinical trial

for children & teens who

experience migraine attacks

By having your child participate in this migraine clinical trial you can help us learn if a study medicine [called rimegepant], taken as an oral dissolving tablet, can treat migraine pain and relieve symptoms in children and teens.

Participants in this trial will receive care from a team of dedicated medical professionals in the context of this trial and help

to advance medical research for children and teens who experience migraine attacks.

This clinical trial is enrolling children & teens who are [6 to less than 18] years of age and:

  • Have experienced migraine attacks for at least 6 months (symptoms of migraine include throbbing headaches that are often sensitive to physical activity, light, sounds or smells).

  • Usually experience 1 to 8 moderate or severe migraine attacks per month.

  • Have migraine attacks that last for approximately more than 3 hours when they are not treated.

There will be other requirements that the trial team will discuss with you.

BMS (Bristol Myers Squibb) CN012-0024 – Alzheimer’s Disease (AD)

If you or someone you know is experiencing agitation related to Alzheimer’s disease, the ADAGIO-2 Study (CN012-0024) may interest you.

Agitation is one of the most common features of Alzheimer’s disease, and it can cause a person to become restless, irritable, upset, or even aggressive. Agitation can significantly impact quality of life for both the person with the condition and their caregivers.

PARTICIPANTS MAY QUALIFY IF THEY:

  • Are 55 to 90 years ofage.

  • Have been diagnosed with Alzheimer’s disease.

  • Have been experiencing physical and/or verbal agitation (e.g., hitting, kicking, shouting, cursing, pacing, wandering, throwing things, resistance to care) for at least 2 weeks.

There are also other requirements. Participants will need to attend a Screening Visit to see if they qualify.

Moderna mRNA-1195-P201 – Relapsing-Remitting Multiple Sclerosis (RRMS)

The Horizon Trial is evaluating the safety and effectiveness of an investigational vaccine to see if it may stop or slow your MS from progressing.

The investigational vaccine is for Epstein-Barr virus (EBV), which can trigger MS or make your symptoms worse.1 Most people with MS have EBV, and research shows EBV as a contributing cause of MS.2,3

This clinical trial is looking for adult participants. To join, you must:

  • Be 18 to 55 years of age.

  • Have been diagnosed with relapsing MS, including clinically isolated syndrome (CIS)*, or radiologically isolated syndrome (RIS)† within the last 2 years.

  • Not be pregnant or planning on becoming pregnant until after the final injection visit.

There will be other requirements that the trial team will discuss with you.

*CIS is when you have had 1 episode of MS symptoms that meet the McDonald 2017 criteria for MS.

†RIS is when you have no MS symptoms yet, but your brain or spinal cord images are typical of MS.

Sanofi EFC17919 – Relapsing Multiple Sclerosis (RMS)

Our research study is exploring an investigational study drug for individuals with relapsing MS, particularly focusing on African American women who experience aggressive symptoms. Your participation could help advance MS research and improve future treatment options.

PARTICIPANTS MAY QUALIFY IF THEY:

  • Be 18 to 55 years of age.

  • Have been diagnosed with relapsing MS, including clinically isolated syndrome (CIS)*, or radiologically isolated syndrome (RIS)† within the last 2 years.

  • Not be pregnant or planning on becoming pregnant until after the final injection visit.

There will be other requirements that the trial team will discuss with you.

PAST RESEARCH STUDIES

CLINICAL TRIAL FAQs

What are clinical trials?

Clinical trials are research studies done to find out if a treatment can improve people’s health. A treatment can be a drug, medical device, medical procedure, or a change in a person’s behavior such as diet or exercise. People who take part in clinical trials are volunteers. They may also be called “participants” or “subjects.”

Are clinical trials safe?

Every clinical trial must be approved and monitored by an Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits. Once the trial is approved by the IRB, the organizers of the study must follow a careful plan, called a protocol, that describes exactly what will happen during the study. You will know the full details of the protocol prior to joining any clinical trial.

Are these medications that have been tried before?

Every medication and treatment has been previously tested on humans and been declared safe for further testing.

Do I need to be previously diagnosed to participate?

You don’t always have to previously be diagnosed, but for some trials a previous diagnosis is required.

How do I know if I am eligible to be in a clinical trial?

All clinical trials have guidelines spelling out who can participate. These are called eligibility criteria. The factors that allow you to participate in a clinical trial can include age, gender, the type and stage of your disease, previous treatment history, and other medical conditions. Following eligibility criteria helps us keep you safe and ensures that researchers learn the information they need.

Can I stay on my current medicine while I’m in the study?

Yes, you can. Most of the time, we require you to be on a stable dose of your prescribed medication during your trial participation.

What are the chances I will get a placebo?

A placebo is a pill or other substance that has no therapeutic effect. If a placebo is part of the trial you’re considering, you will be fully informed of that fact ahead of time. You would only be considered for such a trial when it’s safe and medically appropriate.

What is informed consent?

Informed consent is the process of learning about the clinical trial before you decide to take part in it. The Sharlin Health Research Team will explain the trial’s purpose, how long it will take, what will happen, all potential risks and benefits, and information on the privacy of your medical records. If you want to participate, you will sign a consent form that details all of the information that has been discussed with the research team. You will be able to take that form home and refer to it at any time. Even though you have signed the consent form, you still have the right to leave the study at any time and for any reason. Informed consent continues throughout the trial. This will give the research team an opportunity to update you on the progress of the trial as well as any side effects or other risks that have been identified.

Is it possible to experience side effects during a clinical trial?

There are possible risks, such as adverse events or side effects, to consider when participating in any clinical trial. Participants are informed of known risks or side effects before starting the trial. Risks also are explained in the informed consent document. Make sure you fully understand them. There is always the possibility of unknown risk. If any new side effects or risks are discovered during the trial, you will be informed.

Do I have to pay to be in a clinical trial?

You do not have to pay. SHNRC may compensate study participants for their time and, in some instances, for the inconvenience of a procedure. Compensation varies for each clinical trial. Compensation of over $600 is reportable to the IRS and requires a Form 1099.

Can I stop the trial before it is over?

Yes. Clinical trial participants have the right to change their minds at any time even after they have started the clinical trial or at any time during the trial. It is important to contact the clinical trial site and inform the research team of a decision to stop participating to make sure steps are taken to safely transition a participant back to their previous care.

Will I get any benefit from being in a clinical trial?

The health of millions of people has been improved because of advances in medical care, made possible by clinical trial participants. People choose to participate in clinical trials for a variety of reasons, including the chance to play a more active role in their own health care, gain access to new medical treatments before they are available to the wider public, and help others by contributing to the future of medical science.

How long do clinical trials run?

It depends on the trial; they can vary from days to a number of months or even years. You will be told the expected length of the trial before you start. This information is discussed with you during the informed consent process.

Phone: (417) 238-3301

Email: [email protected]

Location:
5508 N. Farmer Branch Rd.
Ozark, Missouri 65721

DISCLAIMER

Medical Disclaimer. The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. Patient results may vary.

© Sharlin Health Neuroscience Research Center | © Sharlin Health Advanced Imaging | All Rights Reserved.